Flagship Harbor Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-125
| Closed | -$43.8K | – | 1124 |
|
|
2025
Q4 | $43.8K | Buy |
+125
| New | +$42.2K | ﹤0.01% | 1109 |
|
|
2025
Q3 | – | Sell |
-606
| Closed | -$236K | – | 813 |
|
|
2025
Q2 | $236K | Sell |
606
-107
| -15% | -$43K | 0.01% | 678 |
|
|
2025
Q1 | $310K | Sell |
713
-81
| -10% | -$32.5K | 0.02% | 568 |
|
|
2024
Q4 | $293K | Buy |
794
+180
| +29% | +$75.3K | 0.02% | 589 |
|
|
2024
Q3 | $319K | Buy |
614
+1
| +0.2% | +$534 | 0.02% | 535 |
|
|
2024
Q2 | $332K | Buy |
613
+111
| +22% | +$58.7K | 0.02% | 515 |
|
|
2024
Q1 | $261K | Buy |
502
+23
| +5% | +$11.4K | 0.02% | 568 |
|
|
2023
Q4 | $226K | Sell |
479
-19
| -4% | -$8.79K | 0.02% | 563 |
|
|
2023
Q3 | $217K | Buy |
498
+19
| +4% | +$8.62K | 0.02% | 554 |
|
|
2023
Q2 | $213K | Sell |
479
-4
| -0.8% | -$1.84K | 0.02% | 571 |
|
|
2023
Q1 | $222K | Buy |
483
+36
| +8% | +$17.1K | 0.02% | 566 |
|
|
2022
Q4 | $229K | Buy |
+447
| New | +$227K | 0.02% | 540 |
|
|
2022
Q3 | – | Sell |
-461
| Closed | -$222K | – | 595 |
|
|
2022
Q2 | $222K | Sell |
461
-1
| -0.2% | -$495 | 0.02% | 540 |
|
|
2022
Q1 | $227K | Sell |
462
-100
| -18% | -$45.7K | 0.02% | 561 |
|
|
2021
Q4 | $261K | Sell |
562
-63
| -10% | -$26.5K | 0.02% | 535 |
|
|
2021
Q3 | $238K | Hold |
625
| – | – | 0.03% | 555 |
|
|
2021
Q2 | $238K | Buy |
625
+18
| +3% | +$6.88K | 0.03% | 556 |
|
|
2021
Q1 | $218K | Buy |
+607
| New | +$195K | 0.02% | 580 |
|
|
2020
Q4 | – | Sell |
-709
| Closed | -$190K | – | 860 |
|
|
2020
Q3 | $190K | Buy |
709
+102
| +17% | +$27.4K | 0.03% | 477 |
|
|
2020
Q2 | $159K | Buy |
607
+27
| +5% | +$7.2K | 0.02% | 514 |
|
|
2020
Q1 | $132K | Sell |
580
-18
| -3% | -$4.91K | 0.03% | 476 |
|
|
2019
Q4 | $181K | Sell |
598
-29
| -5% | -$7.98K | 0.03% | 457 |
|
|
2019
Q3 | $150K | Sell |
627
-32
| -5% | -$8.77K | 0.03% | 485 |
|
|
2019
Q2 | $185K | Sell |
659
-3
| -0.5% | -$819 | 0.04% | 410 |
|
|
2019
Q1 | $190K | Buy |
662
+117
| +21% | +$33.8K | 0.04% | 408 |
|
|
2018
Q4 | $143K | Buy |
545
+1
| +0.2% | +$275 | 0.03% | 445 |
|
|
2018
Q3 | $150K | Buy |
544
+39
| +8% | +$10.1K | 0.03% | 484 |
|
|
2018
Q2 | $120K | Buy |
+505
| New | +$117K | 0.02% | 524 |
|
Other funds holding ELV
Flagship Harbor Advisors's ELV Position: Q1 2026 in Review
Flagship Harbor Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 125 shares — an estimated $43.8K sold.
Flagship Harbor Advisors first reported a position in ELV in Q2 2018 and held it in 28 quarters. The position peaked at $332K in Q2 2024. 1,468 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Flagship Harbor Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Flagship Harbor Advisors sold 125 Elevance Health shares in Q1 2026, an estimated $43.8K.
- Flagship Harbor Advisors first reported a position in Elevance Health in Q2 2018 and held it in 28 quarters.
- Flagship Harbor Advisors's Elevance Health position peaked at $332K in Q2 2024.
- 1,468 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.